Type 2 diabetes is the most common form of diabetes. Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. Biochempeg has developed and can supply some key intermediates of Semaglutide.
Semaglutide(trade names: Rybelsus,Ozempic) is a medication for the treatment of type 2 diabetes. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. It was given a brand name Ozempic. Clinical trials were started in 2015, and phase 3 was completed in 2016. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
Biochempeg supplies some key intermediates of Semaglutide with high quality & fast shipping. There are 4 kinds of key intermediates of Semaglutide for your research.
Fmoc-NH-PEG2-CH2COOH
CatalogID: 10821 Purity: >=95% CAS NO.: 166108-71-0
Price: $500/100g
NH2-PEG2-CH2COOH
CatalogID: 10803 Purity: >=95% CAS NO.: 134978-97-5
Price: $180/1g $600/5g
Boc-NH-PEG2-CH2COOH
CatalogID: 10852 Purity: >=95% CAS NO.: 108466-89-3
Price: $380/5g $600/10g
CH2COOH-PEG2-NH2.HCl
CatalogID: 12311 Purity: >=95% CAS NO.: 134979-01-4
Price: inquiry
